On the FY2025 financial statements, revenue was KRW 298,936,050, down 57.2% from KRW 698,317,952 in 2024. Over the same period, the operating loss widened to KRW 816,817,327 from KRW 608,006,825 in 2024, and the net loss was KRW 814,744,711.
Gross profit of KRW 225,975,961 in 2024 turned into a gross loss of KRW 26,642,479 in 2025. Selling and administrative expenses fell to KRW 790,174,848 from KRW 830,982,786 but did not offset the revenue decline. R&D expenses charged to expense were KRW 312,856,159 in 2025, close to KRW 313,165,759 in 2024.
According to the company's results commentary, fewer surface treatment product orders, weak TAC equipment sales, fixed-cost burden and higher costs drove the deterioration. Total equity was KRW (142,435,722) as of December 31, 2025, and accumulated deficit reached KRW 13,980,837,975.
On March 23, 2026, trading was suspended for other investor-protection reasons, and a later change notice granted an improvement period. At the March 31, 2026 annual general meeting, three agenda items including approval of financial statements passed.
The last close before the halt, KRW 449, is the displayed price, and turnover is zero during the suspension. Per Investing.com, the 52-week range is KRW 183 to KRW 1,098.